These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells. Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388 [TBL] [Abstract][Full Text] [Related]
43. Distinct Osteomimetic Response of Androgen-Dependent and Independent Human Prostate Cancer Cells to Mechanical Action of Fluid Flow: Prometastatic Implications. González Á; García de Durango C; Alonso V; Bravo B; Rodríguez de Gortázar A; Wells A; Forteza J; Vidal-Vanaclocha F Prostate; 2017 Feb; 77(3):321-333. PubMed ID: 27813116 [TBL] [Abstract][Full Text] [Related]
44. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. De Luca A; Gallo M; Aldinucci D; Ribatti D; Lamura L; D'Alessio A; De Filippi R; Pinto A; Normanno N J Cell Physiol; 2011 Aug; 226(8):2131-8. PubMed ID: 21520065 [TBL] [Abstract][Full Text] [Related]
45. Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis. Shen C; Lie P; Miao T; Yu M; Lu Q; Feng T; Li J; Zu T; Liu X; Li H Mol Med Rep; 2015 Jul; 12(1):20-30. PubMed ID: 25739039 [TBL] [Abstract][Full Text] [Related]
46. Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI. Lee MJ; Heo SC; Shin SH; Kwon YW; Do EK; Suh DS; Yoon MS; Kim JH Int J Biochem Cell Biol; 2013 Aug; 45(8):1869-77. PubMed ID: 23735324 [TBL] [Abstract][Full Text] [Related]
47. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway. Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310 [TBL] [Abstract][Full Text] [Related]
48. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma. Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203 [TBL] [Abstract][Full Text] [Related]
49. Aging up-regulates ARA55 in stromal cells, inducing androgen-mediated prostate cancer cell proliferation and migration. Zou Q; Cui D; Liang S; Xia S; Jing Y; Han B J Mol Histol; 2016 Jun; 47(3):305-15. PubMed ID: 27178620 [TBL] [Abstract][Full Text] [Related]
51. Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells. Rubinstein-Achiasaf L; Morein D; Ben-Yaakov H; Liubomirski Y; Meshel T; Elbaz E; Dorot O; Pichinuk E; Gershovits M; Weil M; Ben-Baruch A Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806906 [TBL] [Abstract][Full Text] [Related]
53. Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. McGuire JJ; Frieling JS; Lo CH; Li T; Muhammad A; Lawrence HR; Lawrence NJ; Cook LM; Lynch CC Nat Commun; 2021 Feb; 12(1):723. PubMed ID: 33526787 [TBL] [Abstract][Full Text] [Related]
54. Small Extracellular Vesicles Released from Ovarian Cancer Spheroids in Response to Cisplatin Promote the Pro-Tumorigenic Activity of Mesenchymal Stem Cells. Vera N; Acuña-Gallardo S; Grünenwald F; Caceres-Verschae A; Realini O; Acuña R; Lladser A; Illanes SE; Varas-Godoy M Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600881 [TBL] [Abstract][Full Text] [Related]
55. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812 [TBL] [Abstract][Full Text] [Related]
56. Interleukin-1α induces immunosuppression by mesenchymal stem cells promoting the growth of prostate cancer cells. Cheng J; Li L; Liu Y; Wang Z; Zhu X; Bai X Mol Med Rep; 2012 Nov; 6(5):955-60. PubMed ID: 22895682 [TBL] [Abstract][Full Text] [Related]
57. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Gnecchi M; Melo LG Methods Mol Biol; 2009; 482():281-94. PubMed ID: 19089363 [TBL] [Abstract][Full Text] [Related]
58. Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer. Windus LC; Glover TT; Avery VM Mol Cancer; 2013 Sep; 12(1):112. PubMed ID: 24073816 [TBL] [Abstract][Full Text] [Related]
59. Hypoxic osteocytes recruit human MSCs through an OPN/CD44-mediated pathway. Raheja LF; Genetos DC; Yellowley CE Biochem Biophys Res Commun; 2008 Feb; 366(4):1061-6. PubMed ID: 18155656 [TBL] [Abstract][Full Text] [Related]
60. Stimulating effect of palmitate and insulin on cell migration and proliferation in PNT1A and PC3 prostate cells: Counteracting role of metformin. Landim BC; de Jesus MM; Bosque BP; Zanon RG; da Silva CV; Góes RM; Ribeiro DL Prostate; 2018 Jul; 78(10):731-742. PubMed ID: 29635803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]